2017
Non-Invasive Assessment of Vascular System Function and Damage Induced by Anthracycline Treatment in the Pediatric Cancer Survivors
BUDINSKAYA, Ksenia, Veronika PUCHNEROVÁ, Jana SVAČINOVÁ, Jan NOVÁK, Hana HRSTKOVÁ et. al.Základní údaje
Originální název
Non-Invasive Assessment of Vascular System Function and Damage Induced by Anthracycline Treatment in the Pediatric Cancer Survivors
Autoři
BUDINSKAYA, Ksenia (643 Rusko, domácí), Veronika PUCHNEROVÁ (203 Česká republika, domácí), Jana SVAČINOVÁ (203 Česká republika, garant, domácí), Jan NOVÁK (203 Česká republika, domácí), Hana HRSTKOVÁ (203 Česká republika, domácí), Marie NOVÁKOVÁ (203 Česká republika, domácí), Anna PEKAŘOVÁ (203 Česká republika, domácí), Matej PEKAŘ (703 Slovensko, domácí) a Zuzana NOVÁKOVÁ (203 Česká republika, domácí)
Vydání
Physiological Research, Praha, Fyziologický ústav AV ČR, 2017, 0862-8408
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30105 Physiology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.324
Kód RIV
RIV/00216224:14110/17:00099503
Organizační jednotka
Lékařská fakulta
UT WoS
000422901400014
Klíčová slova anglicky
Anthracyclines; Cardiotoxicity; Pulse wave velocity; Pulse wave analysis; Arterial stiffness
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 17:02, Soňa Böhmová
Anotace
V originále
Anthracyclines represent one of the important classes of anti-cancer drugs; however, their major disadvantage is their profound cardiovascular toxicity. This study aimed to evaluate influence of anthracyclines on cardiovascular stiffness parameters estimated from pulse wave (PW). PW was measured in 59 cancer survivors treated with anthracyclines in childhood and in 248 healthy age-matched controls. Both patients and controls were divided into three age groups (13 – 15, 16 – 18 and 19 – 24 years). Central PW augmentation index (C-AI75) and augmentation pressure (C-AP75), both normalized to heart rate 75 bpm, were calculated as parameters of arterial wall stiffness. Central Buckberg sub-endocardial viability ratio (SEVR) was calculated as a parameter of diastolic function. Patients and controls were compared in each age group. C-AI75 and C-AP75 were significantly increased in patients in age groups 16 – 18 and 19 – 24 years. SEVR was decreased in patients in the oldest age group. Our results suggest that although toxic influence of anthracyclines to arterial wall and heart are developing during childhood and puberty, they can be detected rather in the adulthood. These changes are yet subclinical; however, their presence ndicates potentially increased cardiovascular risk in childhood cancer survivors treated with anthracyclines during childhood.
Návaznosti
MUNI/A/1355/2016, interní kód MU |
|